Arog Pharmaceuticals, Inc. Contracts & Agreements
12 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (2)
- Human Resources (1)
- Intellectual Property (3)
- Uncategorized (1)
- Form of Arog Pharmaceuticals, Inc. 2018 Long Term Incentive Plan (Filed With SEC on September 28, 2018)
- Offer Letter, dated March 9, 2018, between Arog Pharmaceuticals, Inc. and Dean Ferrigno (Filed With SEC on September 28, 2018)
- License Agreement, dated April 28, 2010, between Arog Pharmaceuticals, Inc. and Pfizer Inc (Filed With SEC on September 28, 2018)
- License Agreement, dated January 5, 2015, between Arog Pharmaceuticals LLC and Videra Pharmaceuticals, LLC (Filed With SEC on September 28, 2018)
- Asset Purchase Agreement, dated January 5, 2015, between Arog Pharmaceuticals, Inc. and Videra Pharmaceuticals, LLC (Filed With SEC on September 28, 2018)
- First Amendment to January 5, 2015 License Agreement, dated June 22, 2018, between Arog Pharmaceuticals, Inc. and Videra Pharmaceuticals, LLC (Filed With SEC on September 28, 2018)
- Master Services Agreement, dated June 12, 2018, between Arog Pharmaceuticals, Inc. and DAVA Oncology, LP (Filed With SEC on September 28, 2018)
- Master Services Agreement, dated June 12, 2018, between Arog Pharmaceuticals, Inc. and Jain Investments, LLC (Filed With SEC on September 28, 2018)
- Stock Purchase and Debt Conversion Agreement, dated January 31, 2017, between Arog Pharmaceuticals, Inc. and Jain Investments, LLC (Filed With SEC on September 28, 2018)
- Loan Agreement, dated as of September 8, 2017, between Arog Pharmaceuticals, Inc. and Jain Investments, LLC (Filed With SEC on September 28, 2018)
- Loan Agreement, dated as of April 11, 2018, between Arog Pharmaceuticals, Inc. and Jain Investments, LLC (Filed With SEC on September 28, 2018)
- First Amendment to April 11, 2018 Loan Agreement, dated May 30, 2018, between Arog Pharmaceuticals, Inc. and Jain Investments, LLC (Filed With SEC on September 28, 2018)
